Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hederagenin ameliorates cisplatin-induced acute kidney injury via inhibiting long non-coding RNA A330074k22Rik/Axin2/β-catenin signalling pathway
Ke-huan Xie, Xiaoheng Liu, Jian Jia, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109247-109247
Open Access | Times Cited: 20

Showing 20 citing articles:

Pharmacological potential of Astragali Radix for the treatment of kidney diseases
Yue Shi, Xiujie Shi, Mingming Zhao, et al.
Phytomedicine (2023) Vol. 123, pp. 155196-155196
Closed Access | Times Cited: 26
Role of renal tubular epithelial cells and macrophages in cisplatin-induced acute renal injury
Jinzhang Gao, Qinxiang Deng, Jun Yu, et al.
Life Sciences (2024) Vol. 339, pp. 122450-122450
Closed Access | Times Cited: 8
A systematic review of epigenetic interplay in kidney diseases: Crosstalk between long noncoding RNAs and methylation, acetylation of chromatin and histone
Ruizhi Tan, Jian Jia, Tong Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116922-116922
Open Access | Times Cited: 7
Astragaloside IV attenuates cadmium induced nephrotoxicity in rats by activating Nrf2
Yuchen Li, Jiayi Zhou, Tianxin Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis
Jian Jia, Ruizhi Tan, Linghui Xu, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112303-112303
Closed Access | Times Cited: 6
Epigenetic regulation of macrophage function in kidney disease: New perspective on the interaction between epigenetics and immune modulation
Ruizhi Tan, Qianrong Bai, Lingfei Jia, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117842-117842
Closed Access
Natural Compounds Regulate Macrophage Polarization and Alleviate Inflammation Against ALI/ARDS
Zhinan Yin, Ruolin Song, Tong Yu, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 192-192
Open Access
Nephroprotective effects of substances of medicine food homology and traditional Chinese medicine phytochemicals against acute kidney injury
Ling Chen, Yanyan Deng, Jing Hu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
RNA-Based Therapies in Kidney Diseases
Liang Hu, Ting Jin, Ning Zhang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3143-3160
Open Access
Hederagenin ameliorates renal fibrosis in chronic kidney disease through blocking ISG15 regulated JAK/STAT signaling
Jian Jia, Linghui Xu, Chong Deng, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110122-110122
Closed Access | Times Cited: 11
Pharmacological overview of hederagenin and its derivatives
Xing Huang, Qing‐Kun Shen, Hongyan Guo, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 10, pp. 1858-1884
Open Access | Times Cited: 11
An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives
Huize Zhang, Li Yong, Yi Liu
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Research Progress on the Anti-Cancer Effects of Astragalus membranaceus Saponins and Their Mechanisms of Action
Feiya Sheng, Siyu Yang, Li Mi, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3388-3388
Open Access | Times Cited: 3
Hederagenin protects against myocardial ischemia–reperfusion injury via attenuating ALOX5-mediated ferroptosis
Li Zhao, Hongtao Shi, Fan Zhang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 3411-3424
Closed Access | Times Cited: 9
Astragalus mongholicus bunge and panax notoginseng formula (A&P) improves renal fibrosis in UUO mice via inhibiting the long non-coding RNA A330074K22Rik and downregulating ferroptosis signaling
Xia Zhong, Yue Huang, Jian Jia, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Hederagenin inhibits high glucose‐induced fibrosis in human renal cells by suppression of NLRP3 inflammasome activation through reducing cathepsin B expression
G. Yang, Yang Wang, Hairong Jiang, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 6, pp. 1409-1420
Open Access | Times Cited: 6
RNA therapeutics for kidney injury
Pouya Goleij, Pantea Majma Sanaye, Aryan Rezaee, et al.
Progress in molecular biology and translational science (2024), pp. 69-95
Closed Access | Times Cited: 1
Hederagenin Improves Adriamycin-induced Nephropathy by Inhibiting the JAK/STAT Signaling Pathway
Xia Zhong, Jian Jia, Ruizhi Tan, et al.
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 2
Closed Access | Times Cited: 1
Kidney Injury: Focus on Molecular Signaling Pathways
Wei Liu, MengDi Hu, Le Wang, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 28, pp. 4510-4533
Closed Access
Bioinformatics and next generation data analysis reveals the potential role of inflammation in sepsis and its associated complications
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top